Pricol-New to hold board meeting

Mumbai, July 9 -- Pricol-New will hold a meeting of the Board of Directors of the Company on 30 July 2026. Published by HT Digital Content Services with permission from Capital Market.... Read More

Siyaram Silk Mills to conduct AGM

Mumbai, July 9 -- Siyaram Silk Mills announced that the Annual General Meeting(AGM) of the company will be held on 1 August 2026. Published by HT Digital Content Services with permission from Capital... Read More

How appeal court verdict against Le Pen puts her back in the running for 2027

France, July 9 -- Despite maintaining the guilty verdict against Le Pen, Tuesday's ruling by the Paris court of appeal worked in the politician's favour. It shortened a ban on public office that woul... Read More

JSW Holdings to conduct AGM

Mumbai, July 9 -- JSW Holdings announced that the Annual General Meeting(AGM) of the company will be held on 6 August 2026. Published by HT Digital Content Services with permission from Capital Marke... Read More

Indian Shares Seen Higher At Open As Oil Prices Fall

India, July 9 -- Indian shares look set to open a tad higher on Friday after oil prices slumped to end a two-day rally overnight on speculation the escalation of hostilities between the U.S. and Iran ... Read More

After outlet park in Sepang, Mitsui Fudosan and MAHB partner for RM80m aviation logistics hub in Subang

SUBANG JAYA, July 9 -- Transport Minister Anthony Loke Siew Fook has hailed a renewed partnership between Malaysia Airports Holdings Berhad (MAHB) and Mitsui Fudosan, signalling a strategic push to ce... Read More

Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, July 9 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in... Read More

Singapore Clinical Trial: An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BAY 3771249 as monotherapy or combination with other cancer treatments in participants with solid tumors harboring a KRAS G12D mutation

Singapore, July 9 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and e... Read More

Singapore Clinical Trial: A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asciminib in pediatric participants newly diagnosed or previously treated with Philadelphia positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) with or without known T315I mutation.

Singapore, July 9 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of ascimi... Read More

Singapore Clinical Trial: A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with chemotherapy followed by asciminib plus blinatumomab in pediatric, adolescent, and young adult participants with relapsed or refractory BCR::ABL1-positive (Philadelphia positive, Ph+) or BCR::ABL1-like (Ph-like) acute lymphoblastic leukemia (ALL)

Singapore, July 9 -- The Health Sciences Authority received information related to the study titled 'A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with ... Read More

• ««
• «
• 339
• 340
• 341
• 342
• 343
• 344
• 345
• 346
• 347
• 348
• »
• »»